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Abstract
We describe a case of sacroiliitis secondary to catheter-related bacteremia due to Mycobacterium abscessus (sensu
stricto). This case confirms that MultiLocus sequence typing and variable-number tandem-repeat methods are very
robust techniques to identify the pathogen species and to validate molecular epidemiological links among complex
M. abscessus isolates.
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Background
Mycobacterium abscessus species are rapidly growing
mycobacteria (RGM) that belong to the group of non-
tuberculous mycobacteria. Many RGM species have been
identified and M. abscessus, M. chelonae and M. fortuitum
are the most important species that cause human diseases.
The M. abscessus complex (i.e., M. abscessus sensu lato) is
the most pathogenic and chemotherapy-resistant RGM [1]
and is divided in three species (M. abscessus sensu stricto,
M. massiliense and M. bolletti) [2] that are consistent with
the MLST clustering. More recently, Leao et al. [3] have
proposed to group together M. bolletii and M. massiliense
and reclassify them as M. abscessus subsp. bolletii. Here,
we present a case of sacroiliitis secondary to catheter-
related bacteremia due to Mycobacterium abscessus (sensu
stricto).
Case report
In January 2007, a 37-year/old woman with fever and in-
fected jugular catheter was admitted to the Emergency
Department of the Montpellier University Hospital. She
had a past history of Münchausen syndrome, a psychiatric
factitious disorder. The patient admitted to injecting her-
self with tap water in his jugular catheter.
The jugular catheter was inserted one month earlier
for empiric antibiotic administration (ceftriaxone and
trimethoprim-sulfamethoxazole) at home to treat a radio-
logically suspected sacroiliitis with negative microbio-
logical investigations of the bone biopsy. Indeed, bone
biopsy specimen culture in Columbia sheep blood agar,
Chocolate agar, MacConkey agar (BioMérieux, Lyon,
France) and Schaedler broth (Becton, Dickinson) as well
as the specific research of mycobacterial infection using
the BacT/ALERT®3D automated culture system (Bio-
Mérieux, Lyon, France) and solid Löwenstein-Jensen (LJ)
medium remained negative after 10 days and 12 weeks,
respectively. On the basis of clinical and radiological
signs, non-infectious sacroiliitis was excluded. After re-
moval, the jugular catheter was cultured on blood agar
according to the Brun-Buisson quantitative broth dilu-
tion culture technique [4]. Two sets of peripheral blood
cultures were established in BacT/ALERT aerobic and
anaerobic resin bottles (BioMérieux, Lyon, France). After
incubation at 37°C using the BacT/ALERT®3D system
(BioMérieux, Lyon, France) for two days, the two aerobic
blood cultures became positive for a pleomorphic Gram-
positive bacillus. Subcultures of the two aerobic blood cul-
tures and of the catheter culture were performed on
Columbia sheep blood agar and after three additional days
* Correspondence: godreuil@yahoo.fr
1Centre Hospitalier Régional Universitaire (CHRU) de Montpellier,
Département de Bactériologie-Virologie, Montpellier, France
6Université Montpellier 1, Montpellier, France
Full list of author information is available at the end of the article
© 2014 Laurens et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Laurens et al. Annals of Clinical Microbiology and Antimicrobials 2014, 13:9
http://www.ann-clinmicrob.com/content/13/1/9
of incubation, the growth of an irregular Gram-positive,
rod-shaped and strictly aerobic organism was observed
in all three. Catalase production was detected. Micro-
scopic analysis of the three subcultures after Ziehl-
Neelsen (ZN) staining revealed the presence of acid-fast
bacilli (AFB) consistent with mycobacteria. After sub-
culture on Middlebrook medium, growth of rough,
non-pigmented colonies was noted within five days. The
commercial GenoType Mycobacterium CM multiplex line
probe assay (Hain Lifescience, Nehren, Germany) identi-
fied the organism as Mycobacterium abscessus. As the pa-
tient did not present symptoms, pelvic radiograph did not
detect radiological progression of sacroiliitis and fever dis-
appeared 48 hours after catheter removal, no additional
microbiological examination (e.g., sets of peripheral blood
cultures) has been made and antimicrobial therapy was
postponed. Into the post-hospitalization period, the lack
of compliance in this patient did not allow regular medical
monitoring. Eight months later, the patient was hospital-
ized again for severe progression of sacroiliitis (confirmed
by computed tomography scan imaging) associated with
fistulization to the skin and fever. Fluid from the fistula
was collected by fine-needle aspiration for bacteriological
investigations. Direct microscopic examination after ZN
staining showed the presence of AFB and the mycobac-
terial infection was confirmed by culture. By using the
same routine molecular investigations as before, the fis-
tula isolate was identified as M. abscessus. Oral anti-
mycobacterial therapy (clarithromycin + ethambutol +
ciprofloxacin) was started and continued for a total
period of eight months followed by one month treat-
ment with clarithromycin alone. The minimum inhi-
bitory concentrations (MICs) of different antimicrobial
drugs on the four isolates was determined using broth
microdilution panels (Sensititre RAPMYCO; Trek Diag-
nosis Systems, Cleveland, Ohio, USA) [5]. The method
and guidelines for the interpretation of results were
those of the Clinical and Laboratory Standards Institute
[6]. The test results were identical for the four isolates
and confirmed resistance to doxycycline (MIC ≥ 16 μg/
ml), trimethoprim-sulfamethoxazole (MIC: 8/152 μg/ml)
and susceptibility to amikacin (MIC: 2 μg/ml), cefoxitin
(MIC: 8 μg/ml), ciprofloxacin (MIC: 1 μg/ml), clarithro-
mycin (MIC: 0.125 μg/ml), imipenem (MIC: 2 μg/ml),
linezolid (MIC: 2 μg/ml) and intermediate susceptibility
to moxifloxacin (MIC: 2 μg/ml). For clarithromycin, the
same MIC value was obtained after 5 days and 14 days
of incubation. Six months after the end of the antibiotic
therapy, the patient was well without fever or clinical
and radiological signs of disease progression.
The four clinical isolates (two from blood, one from
the catheter and one from the sacroiliac fistula) were
then characterized by using the Multilocus Sequence
Typing method (MLST), based on seven housekeeping
genes (argH, cya, glpK, gnd, murC, pta and purH) [1]. Al-
lele and sequence type (ST) queries were performed dir-
ectly using the M. abscessus MLST database (http://www.
pasteur.fr/recherche/genopole/PF8/mlst/Myco-abscessus.
html). A phylogenetic tree was generated, based on the
nucleotide sequences of the supergene obtained by concat-
enating the seven loci for the four clinical isolates and
three reference strains (M. abscessus CIP 104536 T, M.
massiliense CIP 108297 T, M. bolletii CIP 108541 T),
using the MEGA software, version 5.2 (www.megasoft-
ware.net/) (data not shown). The four mycobacterial iso-
lates were assigned to the type strain of M. abscessus
(sensu stricto). To assess the clonal links, the four isolates
were genotyped by using the variable-number tandem-
repeat (VNTR) method (with a 15-locus set) associated
with MLST analysis (Figure 1) [7,8]. The four isolates had
the same sequence type (ST1, which corresponds to the M.
abscessus (sensu stricto) type strain) and the same VNTR
profile, based on the analysis of the 15 loci (Figure 1).
Discussion
M. abscessus is an ubiquitous organism found in soil and
water, worldwide [9]. The most common clinical manifest-
ation of M. abscessus infection is probably chronic lung in-
fection, usually in elderly women with bronchiectasis or in
young adults with cystic fibrosis [10]. M. abscessus infec-
tions are commonly localized to skin and soft tissues, es-
pecially after trauma or surgery. Disseminated infections
are infrequent and occur especially in immunocomprom-
ised hosts [11]. Su et al. [12] described a patient in whom
catheter-related M. abscessus bacteremia was confirmed
by positive blood cultures. M. abscessus infections have
also been associated with injection of contaminated nor-
mal saline and drugs [12]. Usually, the entry route in the
organism is known. In our case, the patient (who has a
factitious disorder) injected tap water in her central ven-
ous catheter. Some studies have reported the presence of
M. abscessus in tap water, and its ability to form biofilms
and to resist to chlorine contributes to its survival and
colonization of the water distribution systems [13,14]. Al-
though no investigation was performed to confirm the
presence of the same organism in the patient’s environ-
ment, the mycobacterial isolate could have been intro-
duced in the blood circulation by contamination of the
catheter through the injection of tap water. However,
a secondary bone infection or osteomyelitis due to M.
abscessus bacteremia is infrequent and, classically, M.
abscessus bacteremia has an indolent course in patients
and animal models [12]. In our case, the unusual severity
of the disease (sacroiliitis) could have been caused by dif-
ferent factors, such as (i) the presence of a pre-existing
sacroiliac joint lesion that could have facilitated the M.
abscessus infection; (ii) the infection by a rough strain of
M. abscessus with more virulence factors than smooth
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strains [15-17]; (iii) the lack of treatment after the identifi-
cation of M. abscessus species in the catheter and blood
specimens.
The major threat posed by M. abscessus is its antibiotic
resistance. This species is probably the most resistant spe-
cies among pathogenic RGMs [9,18] and its antimicrobial
treatment remains a challenge. Therapy duration and the
antimicrobial regimens for catheter-related M. abscessus
bacteremia complicated by osteomyelitis are not clearly de-
fined because of the lack of controlled trials to determine
the optimal treatment [19,20]. Combination therapy with at
least two effective parenteral agents (amikacin plus cefoxi-
tin, or imipenem), followed by oral clarithromycin mono-
therapy for weeks to months, has been suggested [18].
Moreover, in the case of catheter-related RGM bacteremia,
removal of the catheter is essential because of the high rate
of uncontrolled or relapsing bacteremia, even after pro-
longed antimicrobial therapy. In the present case, despite
inappropriate antimycobacterial treatment (an initial paren-
teral antimycobacterial treatment with amikacin and cefoxi-
tin, or imipenem was not carried out), the patient did not
present clinical and radiological evidence of sacroiliitis
relapse.
The diagnosis of disseminated RGM infection secondary
to catheter-related RGM bacteremia presented several diffi-
culties. Indeed, the definition of catheter-related bacteremia
must follow specific criteria: presence of clinical features of
bloodstream infection; growth of the same microorganism
in the peripheral blood and the catheter; and absence
of other apparent sources of infection [21]. Moreover,
the interval between the diagnosis of catheter infection,
catheter-related bacteremia (positive blood culture) and
positive deep infection site (visceral, osteo-articular) culture
was of several months. The combination of VNTR and
MLST-based DNA fingerprinting is a practical discrimin-
atory procedure to confirm epidemiological molecular
links among different M. abscessus isolates. Indeed, these
molecular tools have been successfully used to explore the
genetic links among intra- or inter-patients’ M. abscessus
isolates, such as in a cohort of pediatric patients with cystic
fibrosis [7,8,22,23]. In our case, the genetic data strongly
suggest that the sacroiliitis secondary to catheter-related
bacteremia was due to the same M. abscessus (sensu
stricto) isolate from the infected jugular catheter.
Although the differentiation of M. abscessus, M. massi-
liense and M. bolletii does not comply with the latest
nomenclature recommendations [3], it still retains some
sense concerning, for instance, the differences in macro-
lides resistance [24] or in disease phenotype and progres-
sion [23]. MLST (targeting 7 housekeeping genes) and
multi-spacer sequence analysis are considered very robust
methods for identifying species within the M. abscessus
complex [1]. However, these techniques require genomic
sequencing that is relatively costly and time consuming.
Recently, Shallom et al. described a simple and not expen-
sive Polymerase Chain Reaction (PCR)-based method to
differentiate M. abscessus from M. massiliense and M.
bolletii and to subtype M. abscessus and M. massiliense
isolates [25]. Moreover, matrix-assisted laser desorption
ionization–time of flight mass spectrometry (MALDI-
TOF MS) [26] was recently used to efficiently differentiate
the species of the M. abscessus complex. This technology
appears to be a good alternative to the MLST method.
Conclusion
In conclusion, we reported a documented case of sacro-
iliitis secondary to catheter-related bacteremia due to
Mycobacterium abscessus (sensu stricto). RGM are in-
frequently involved in catheter-related infections compli-
cated by disseminated infections. Molecular identification
methods and drug susceptibility testing are essential for
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Figure 1 Tree derived by using the unweighted pair group method with average linkages (UPGMA) based on combined data, MLST2
patterns (including those from the analysis of argH, cya, glpK, gnd, murC, pta and purH) and VNTR3 profiles (including those from the
analysis of 3416, 4356, 3163, 4038, 4093, 3320, 2177, 3398, 2220, TR45, TR109, TR116, TR150, TR155, TR172 and NA = not available)
(7, 22) of the four human isolates and three reference strains. Sequence types (ST)1.
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